These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 23067080)

  • 1. Mortality from acquired bullous diseases of skin in Canadian adults 2000-2007.
    Baibergenova AT; Weinstock MA; Shear NH
    Int J Dermatol; 2012 Nov; 51(11):1325-8. PubMed ID: 23067080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of bullous pemphigoid and pemphigus in Switzerland: a 2-year prospective study.
    Marazza G; Pham HC; Schärer L; Pedrazzetti PP; Hunziker T; Trüeb RM; Hohl D; Itin P; Lautenschlager S; Naldi L; Borradori L;
    Br J Dermatol; 2009 Oct; 161(4):861-8. PubMed ID: 19566661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mortality of bullous skin disorders from 1979 through 2002 in the United States.
    Risser J; Lewis K; Weinstock MA
    Arch Dermatol; 2009 Sep; 145(9):1005-8. PubMed ID: 19770439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral lesions in patients with pemphigus vulgaris and bullous pemphigoid.
    Budimir J; Mihić LL; Situm M; Bulat V; Persić S; Tomljanović-Veselski M
    Acta Clin Croat; 2008 Mar; 47(1):13-8. PubMed ID: 18714642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bullous pemphigoid and pemphigus vulgaris--incidence and mortality in the UK: population based cohort study.
    Langan SM; Smeeth L; Hubbard R; Fleming KM; Smith CJ; West J
    BMJ; 2008 Jul; 337(7662):a180. PubMed ID: 18614511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mortality of bullous pemphigoid in Switzerland: a prospective study.
    Cortés B; Marazza G; Naldi L; Combescure C; Borradori L;
    Br J Dermatol; 2011 Aug; 165(2):368-74. PubMed ID: 21574978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Geographic variations in epidemiology of two autoimmune bullous diseases: pemphigus and bullous pemphigoid.
    Alpsoy E; Akman-Karakas A; Uzun S
    Arch Dermatol Res; 2015 May; 307(4):291-8. PubMed ID: 25589418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency of adverse events associated with intravenous immunoglobulin therapy in patients with pemphigus or pemphigoid.
    Gürcan HM; Ahmed AR
    Ann Pharmacother; 2007 Oct; 41(10):1604-10. PubMed ID: 17785614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spectrum of autoimmune bullous diseases in Kuwait.
    Nanda A; Dvorak R; Al-Saeed K; Al-Sabah H; Alsaleh QA
    Int J Dermatol; 2004 Dec; 43(12):876-81. PubMed ID: 15569006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Profile of bullous pemphigoid. A report of 47 cases].
    Triki Ben Ammar S; Mokhtar I; Fazaa B; Kharfi M; Kamoun MR
    Tunis Med; 2000 Oct; 78(10):584-8. PubMed ID: 11190743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of intravenous immunoglobulin therapy for skin disease other than toxic epidermal necrolysis: a retrospective review of Mayo Clinic experience.
    Wetter DA; Davis MD; Yiannias JA; Gibson LE; Dahl MV; el-Azhary RA; Bruce AJ; Lookingbill DP; Ahmed I; Schroeter AL; Pittelkow MR
    Mayo Clin Proc; 2005 Jan; 80(1):41-7. PubMed ID: 15667028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Annual incidence and mortality of bullous pemphigoid in the Grampian Region of North-east Scotland.
    Gudi VS; White MI; Cruickshank N; Herriot R; Edwards SL; Nimmo F; Ormerod AD
    Br J Dermatol; 2005 Aug; 153(2):424-7. PubMed ID: 16086760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective analysis of the incidence of autoimmune bullous disorders in Lower Franconia, Germany.
    Bertram F; Bröcker EB; Zillikens D; Schmidt E
    J Dtsch Dermatol Ges; 2009 May; 7(5):434-40. PubMed ID: 19170813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The incidence of internal malignancies in autoimmune bullous diseases.
    Iwashita K; Matsuyama T; Akasaka E; Mizutani K; Yamamoto K; Kondoh A; Nozawa M; Yagi Y; Ikoma N; Mabuchi T; Shinagawa H; Tamiya S; Nuruki H; Ohta Y; Umezawa Y; Ozawa A
    Tokai J Exp Clin Med; 2007 Mar; 32(1):42-7. PubMed ID: 21319056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pemphigus and pemphigoid.
    Matsuoka LY
    Am Fam Physician; 1981 Aug; 24(2):113-5. PubMed ID: 7020393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pemphigus and pemphigoid].
    Stewart WM
    Dermatologica; 1980; 160(4):217-35. PubMed ID: 6987108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bullous pemphigoid with pemphigus type antibodies in vivo. 2 cases].
    Bernard P; Catanzano G; Vignaud St Florent JD; Fayol J; Bonnetblanc JM
    Ann Dermatol Venereol; 1986; 113(8):671-6. PubMed ID: 3541760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Some factors affecting prognosis in pemphigus vulgaris and pemphigoid.
    Savin JA
    Br J Dermatol; 1981 Apr; 104(4):415-20. PubMed ID: 7016161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enzyme-linked immunosorbent assay in autoimmune blistering diseases: preliminary experience of the Dermatology Department of Cagliari.
    Atzori L; Deidda S; Aste N
    G Ital Dermatol Venereol; 2008 Feb; 143(1):1-8. PubMed ID: 18833046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency of IgA antibodies in pemphigus, bullous pemphigoid and mucous membrane pemphigoid.
    Cozzani E; Drosera M; Parodi A; Carrozzo M; Gandolfo S; Rebora A
    Acta Derm Venereol; 2004; 84(5):381-4. PubMed ID: 15370705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.